UCB Group, Altea Therapeutics Leaders Elected Georgia Bio Co-Chairs for 2008
ATLANTA--(BUSINESS WIRE)--UCB’s U.S. President Fabrice Egros, Ph.D., and Altea Therapeutics President and CEO Eric Tomlinson, DSc, Ph.D., were elected co-chairs of Georgia Bio’s Board of Directors for 2008. Drs. Egros and Tomlinson succeed AtheroGenics President and CEO Russell Medford, M.D., Ph.D. Dr. Medford will remain on the Georgia Bio Board and Executive Committee as Immediate past Chair.